The following abstracts represent the oral presentations given at IWWM-12 (Prague-2024), Session 19: Plenary Session II

Session Chairs: Ranjana Advani, Meletios Dimopoulos

Phase I Study of the Novel BCL2 Inhibitor Sonrotoclax in Relapsed/Refractory WM Garcia Sanz (Spain)

Zanubrutinib in Bing Neel Syndrome: Efficacy and Tolerability Becking (The Netherlands)

Real World Outcomes of ASCT in Patients with WM: Report from LWP EBMT Kyriakou (UK)

Novel BiFunctional HCK/BTK Protacs for MYD88 Mutated WM and ABC DLBCL Hatcher (USA)

Prague 2024 (IWWM-12)

Prague 2024 Conference Chairs

  • Christian Buske MD, PhD (Ulm University)
  • Jeffrey Matous, MD (Colorado Blood Cancer Institute)
  • Steven Treon, MD, PhD (Dana-Farber)
  • Chris Patterson - Secretariat (Dana-Farber)

The Prague 2024 Scientific Committee members:

Ranjana Advani, MD (USA)
Xinxin Cao, MD (China)
Jorge Castillo, MD (USA)
Ramon Garcia Sanz, MD PhD (Spain)
Moshe Gatt, MD HMO (Israel)
Prashant Kapoor, MD (USA)
Efstathios Kastritis, MD (Greece)
M.J. Kersten, MD PhD AMC (NL)
Merav Leiba, MD (Israel)
Lugui Qiu, MD (China)
Naohiro Sekiguchi, MD, PhD (Japan)
Constantine Tam, MD, FRACP, FRCPA (Aus)
Alessandra Tedeschi, MD (Italy)
Judith Trotman, MD, FRACP, FRCPA (Aus)
Marzia Varettoni, MD (Italy)